A New Class of Gold(I) NHC Complexes with Proapoptotic and Resensitizing Properties towards Multidrug Resistant Leukemia Cells Overexpressing BCL-2

Franziska Bannwart, Leon F. Richter, Simon Stifel, Johanna Rueter, Holger N. Lode, João D.G. Correia, Fritz E. Kühn, Aram Prokop

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung

Abstract

From previous studies, it is evident that metal-organic gold(I) complexes have antiproliferative activities. The aim of this study is not only to find new anticancer agents but also to overcome existing cytostatic resistance in cancer cells. The synthesis and medicinal evaluation of two cationic 1,3-disubstituted gold(I) bis-tetrazolylidene complexes 1 and 2 are reported. To determine apoptosis-inducing properties of the complexes, DNA fragmentation was measured using propidium iodide staining followed by flow cytometry. Gold(I) complex 1 targets explicitly malignant cells, effectively inhibiting their growth and selectively inducing apoptosis without signs of necrosis. Even in cells resistant to common treatments such as doxorubicin, it overcomes multidrug resistance and sensitizes existing drug-resistant cells to common cytostatic drugs. It is assumed that gold(I) complex 1 involves the mitochondrial pathway in apoptosis and targets members of the BCL-2 family, enhancing its potential as a therapeutic agent in cancer treatment.

OriginalspracheEnglisch
Seiten (von - bis)15494-15508
Seitenumfang15
FachzeitschriftJournal of Medicinal Chemistry
Jahrgang67
Ausgabenummer17
DOIs
PublikationsstatusVeröffentlicht - 12 Sept. 2024

Fingerprint

Untersuchen Sie die Forschungsthemen von „A New Class of Gold(I) NHC Complexes with Proapoptotic and Resensitizing Properties towards Multidrug Resistant Leukemia Cells Overexpressing BCL-2“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren